Literature DB >> 1370331

Bladder cancer cells express functional receptors for granulocyte-colony stimulating factor.

T Ohigashi1, M Tachibana, H Tazaki, K Nakamura.   

Abstract

The effects of human recombinant granulocyte-colony stimulating factor (G-CSF) on the growth of cultured human bladder cancer cells and G-CSF receptor on these cells were investigated. Human bladder cancer cell lines, KU-1 or NBT-2, were incubated with and without G-CSF. At 48 hours, 3H-thymidine uptake of both cells was significantly higher with G-CSF (one ng./ml., 10 ng./ml.) than that of control without G-CSF (p less than 0.05). The binding of 125I-labeled KW-2228, a muteins of G-CSF, to KU-1 and NBT-2 was inhibited by unlabeled KW-2228 in a dose-dependent manner. These results demonstrated that G-CSF stimulates the clonal growth of human bladder cancer cells by binding to its specific receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370331     DOI: 10.1016/s0022-5347(17)37214-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Laryngeal squamous cell carcinoma with ectopic production of granulocyte colony-stimulating factor and parathyroid hormone-related protein.

Authors:  Kohtaroh Tanaka; Ken-ichi Nibu
Journal:  Int J Clin Oncol       Date:  2005-06       Impact factor: 3.402

2.  Enhanced gene expression of transforming growth factor-alpha and c-met in rat urinary bladder cancer.

Authors:  M Inui; N Nishi; A Yasumoto; I Takenaka; H Miyanaka; K Matsumoto; T Nakamura; F Wada
Journal:  Urol Res       Date:  1996

Review 3.  Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings.

Authors:  J E Frampton; Y E Yarker; K L Goa
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

4.  Inhibitory effects on in vitro cell growth of human urothelial tumor cell lines under the combined administration of hematopoietic growth factors and clinically relevant antineoplastic agents.

Authors:  T Block; U Treiber; B Geffken; M Vogel; A R Hanauske; F Schmid; R Hartung; R Busch
Journal:  Urol Res       Date:  1993-05

5.  Direct and indirect effects of recombinant human granulocyte-colony stimulating factor on in vitro colony formation of human bladder cancer cells.

Authors:  I A Shameem; H Kurisu; H Matsuyama; T Shimabukuro; K Naito
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

6.  Granulocyte colony-stimulating factor receptor expression on human transitional cell carcinoma of the bladder.

Authors:  M Tachibana; A Miyakawa; A Uchida; M Murai; K Eguchi; K Nakamura; A Kubo; J I Hata
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Serum G-CSF May Be a More Valuable Biomarker than Image Evaluation in G-CSF-Producing Urothelial Carcinoma: A Case Report.

Authors:  Kento Morozumi; Shunichi Namiki; Takashi Kudo; Masataka Aizawa; Naomasa Ioritani
Journal:  Case Rep Oncol       Date:  2017-04-24

8.  Paraneoplastic Leukemoid Reaction after Primary Tumor Resection in Patients with Urothelial Carcinoma: A Report of 2 Cases.

Authors:  Shien-Tung Pan; Shu-Ping Tseng; Chiou-Huey Wang; Yu-Ting Chou
Journal:  Clin Pathol       Date:  2021-07-12

Review 9.  Leukemoid reaction and autocrine growth of bladder cancer induced by paraneoplastic production of granulocyte colony-stimulating factor--a potential neoplastic marker: a case report and review of the literature.

Authors:  Anup Kasi Loknath Kumar; Megha Teeka Satyan; Jeffrey Holzbeierlein; Moben Mirza; Peter Van Veldhuizen
Journal:  J Med Case Rep       Date:  2014-05-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.